CN1671734A - 用于治疗囊性纤维化的cftr修饰基因和表达的多肽以及检测和/或鉴定它们的方法和产品 - Google Patents

用于治疗囊性纤维化的cftr修饰基因和表达的多肽以及检测和/或鉴定它们的方法和产品 Download PDF

Info

Publication number
CN1671734A
CN1671734A CNA038183471A CN03818347A CN1671734A CN 1671734 A CN1671734 A CN 1671734A CN A038183471 A CNA038183471 A CN A038183471A CN 03818347 A CN03818347 A CN 03818347A CN 1671734 A CN1671734 A CN 1671734A
Authority
CN
China
Prior art keywords
cftr
modifying factor
benzoglyoxaline
protein
instrumentality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038183471A
Other languages
English (en)
Chinese (zh)
Inventor
杰弗里·A·惠蔡特
布鲁斯·J·阿罗诺
琼·C·京拉克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Original Assignee
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center filed Critical Cincinnati Childrens Hospital Medical Center
Publication of CN1671734A publication Critical patent/CN1671734A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CNA038183471A 2002-05-31 2003-05-30 用于治疗囊性纤维化的cftr修饰基因和表达的多肽以及检测和/或鉴定它们的方法和产品 Pending CN1671734A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38485502P 2002-05-31 2002-05-31
US38485602P 2002-05-31 2002-05-31
US60/384,855 2002-05-31
US60/384,856 2002-05-31

Publications (1)

Publication Number Publication Date
CN1671734A true CN1671734A (zh) 2005-09-21

Family

ID=29715352

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038183471A Pending CN1671734A (zh) 2002-05-31 2003-05-30 用于治疗囊性纤维化的cftr修饰基因和表达的多肽以及检测和/或鉴定它们的方法和产品

Country Status (6)

Country Link
EP (1) EP1513870A4 (fr)
JP (1) JP2005528449A (fr)
CN (1) CN1671734A (fr)
AU (1) AU2003238791A1 (fr)
CA (1) CA2488012A1 (fr)
WO (1) WO2003102140A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101392026B (zh) * 2008-10-09 2011-11-09 黄岚 用于预防和治疗纤维化类疾病以及肝癌的多肽
CN103025889A (zh) * 2010-03-22 2013-04-03 艾索特里克斯遗传实验室有限责任公司 与囊性纤维化关联的突变
CN105142676A (zh) * 2013-03-14 2015-12-09 夏尔人类遗传性治疗公司 Cftr mrna组合物以及相关方法和用途
CN109280704A (zh) * 2018-10-12 2019-01-29 郑州大学第附属医院 Rasd1作为标志物在制备b-all诊断和预后评估试剂盒中的应用
CN113164425A (zh) * 2018-10-30 2021-07-23 佛罗里达大学研究基金会公司 用于治疗囊性纤维化的氨基酸组合物和方法
CN113604583A (zh) * 2021-08-10 2021-11-05 河南省畜牧总站 一种山羊kcnj15基因cnv标记辅助检测生长性状的方法及其专用试剂盒

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013021399A1 (fr) * 2011-08-05 2013-02-14 Council Of Scientific & Industrial Research Diterpènes pimaranes provenant de anisochilus verticillatus
WO2014058974A1 (fr) * 2012-10-10 2014-04-17 Emory University Méthodes de gestion d'inflammation au moyen d'inhibiteurs de la voie de la glycolyse
US20240076682A1 (en) * 2022-08-29 2024-03-07 Universita' Degli Studi Di Bari Aldo Moro Promoter of the transcription of nucleic acid sequence an its use

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101392026B (zh) * 2008-10-09 2011-11-09 黄岚 用于预防和治疗纤维化类疾病以及肝癌的多肽
CN103025889A (zh) * 2010-03-22 2013-04-03 艾索特里克斯遗传实验室有限责任公司 与囊性纤维化关联的突变
CN103025889B (zh) * 2010-03-22 2015-11-25 艾索特里克斯遗传实验室有限责任公司 与囊性纤维化关联的突变
CN105142676A (zh) * 2013-03-14 2015-12-09 夏尔人类遗传性治疗公司 Cftr mrna组合物以及相关方法和用途
CN105142676B (zh) * 2013-03-14 2022-06-28 夏尔人类遗传性治疗公司 Cftr mrna组合物以及相关方法和用途
CN109280704A (zh) * 2018-10-12 2019-01-29 郑州大学第附属医院 Rasd1作为标志物在制备b-all诊断和预后评估试剂盒中的应用
CN113164425A (zh) * 2018-10-30 2021-07-23 佛罗里达大学研究基金会公司 用于治疗囊性纤维化的氨基酸组合物和方法
CN113604583A (zh) * 2021-08-10 2021-11-05 河南省畜牧总站 一种山羊kcnj15基因cnv标记辅助检测生长性状的方法及其专用试剂盒
CN113604583B (zh) * 2021-08-10 2024-04-02 河南省畜牧总站 一种山羊kcnj15基因cnv标记辅助检测生长性状的方法及其专用试剂盒

Also Published As

Publication number Publication date
JP2005528449A (ja) 2005-09-22
EP1513870A4 (fr) 2006-06-07
EP1513870A2 (fr) 2005-03-16
AU2003238791A1 (en) 2003-12-19
WO2003102140A2 (fr) 2003-12-11
CA2488012A1 (fr) 2003-12-11
WO2003102140A3 (fr) 2004-06-10

Similar Documents

Publication Publication Date Title
CN1604968A (zh) 基于tcf1基因多态性治疗糖尿病和相关病症的方法
CN1466466A (zh) 心衰治疗剂
CN1196797C (zh) 青光眼的诊断和治疗药物
CN1612941A (zh) 基于cntf基因的多态性治疗精神病和精神分裂症的方法
CN1671734A (zh) 用于治疗囊性纤维化的cftr修饰基因和表达的多肽以及检测和/或鉴定它们的方法和产品
CN1533435A (zh) 用于诊断及治疗胰岛素抗性及相关病症之方法和试剂
CN1950512A (zh) 重组穿孔素、其表达和用途
CN1509337A (zh) IFNα-17基因的新的多核苷酸和多肽
CN1791421A (zh) 诱导乳腺上皮细胞分化的方法
CN1620466A (zh) 胱氨酸结折迭蛋白质
CN1708589A (zh) Cns中crh应答基因
CN1812998A (zh) 分泌性蛋白质家族
CN101056990A (zh) 表皮生长因子受体基因启动子的多态性
CN1211486C (zh) 编码前神经肽y原突变体,一种信号肽的突变体,的dna分子及其应用
CN1942480A (zh) 与高脂血症、血脂障碍和糖代谢缺陷相关的SNPs的鉴别
CN1749415A (zh) 硝酸甘油治疗急性心绞痛疗效检测方法和试剂盒
CN1708511A (zh) 对促肾上腺皮质激素释放激素刺激的应答而表达增加的基因
US20050158747A1 (en) CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
CN1303102C (zh) 利用人和鼠Rhor基因及其编码产物诊断和治疗秃发的方法
CN1662262A (zh) 治疗和/或预防Th2细胞因子相关变态反应病的诱骗物、GATA3突变蛋白、和包含它们的药物组合物
CN1564944A (zh) 泛醌缺乏的表型效应及其筛选方法
CN1494592A (zh) 在肥胖型动物下丘脑或肌肉组织中表达的核酸
CN1764722A (zh) 环amp效应元件激活蛋白及其相关用途
JP2003506074A (ja) 薬剤標的同質遺伝子：免疫グロブリンｅ受容体ｉａｌｐｈａサブユニット遺伝子における多型
CN1597980A (zh) 电压调控钠通道7型α亚单位基因与原发性高血压的相关性

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned